Cathie Wood's ARK Buys $77.6 Million of Anthropic on Debut Day, Keeps Trimming NVIDIA

Deep News15:21

On November 20, ARK, the firm led by Cathie Wood, released its latest trading records.

On November 19, ARK purchased a combined 934,968 shares of Anthropic through six of its ETFs, with a transaction value of roughly $77.6 million, making it the largest single trade of the day.

At the same time, ARK continued to reduce its holdings in NVIDIA (NVDA) and trimmed positions in some biotechnology and cryptocurrency-related assets.

Major Buy Trades

Company / Shares Bought / Transaction Value: Anthropic (ANT) 934,968 shares / $77.6023 million; Twist Bioscience (TWST) 18,151 shares / $2.1119 million; GeneDx (WGS) 38,858 shares / $2.0191 million; Kodiak AI (KDK) 882,530 shares / $935,500.

ARK's six ETFs — ARKK, ARKQ, ARKW, ARKG, ARKF and ARKX — all took part in the Anthropic purchase.

In addition, ARK continued to add to its position in autonomous driving technology company Kodiak AI, extending its recent trend of increasing its stake in the company.

Major Sell Trades

Company or Fund / Shares Sold / Transaction Value: NVIDIA (NVDA) 33,430 shares / $5.0466 million; Eli Lilly (LLY) 2,094 shares / $2.8955 million; Adaptive Biotechnologies (ADPT) 93,430 shares / $2.659 million; CareDx (CDNA) 28,095 shares / $2.0914 million; Garmin (GRMN) 2,803 shares / $783,500; Heico (HEI) 2,134 shares / $721,900.

Among these, ARK sold 33,430 shares of NVIDIA (NVDA) through ARKQ, continuing the reduction in the company it began earlier in the week.

On the cryptocurrency-related side, ARK also sold 425,000 shares of the 3iQ Ethereum Staking ETF and 200,000 shares of the 3iQ Solana Staking ETF, cashing out a total of about $4.0885 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment